United Therapeutics | UTHR - Acreedores Comerciales





Acreedores Comerciales Cambio Fecha
Amarin USD 48.15M 2.8M 2026-03
Ardelyx USD 28.2M 8.96M 2026-03
Baxter International USD 1.09B 87M 2026-03
Bayer EUR 6.59B 496M 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Biogen USD 358.5M 73.5M 2026-03
BioMarin Pharmaceutical USD 793.15M 34.12M 2026-03
Emergent BioSolutions USD 112.2M 500K 2023-12
Esperion Therapeutics USD 68.41M 3.34M 2026-03
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Halozyme Therapeutics USD 14.1M 6.8M 2026-03
Insmed USD 73.38M 6.53M 2026-03
Ionis Pharmaceuticals USD 26.03M 2.05M 2026-03
J&J USD 10.46B 1.53B 2026-03
Lexicon Pharmaceuticals USD 3M 87K 2026-03
Moderna USD 161M 156M 2026-03
Omeros USD 8.84M 4.42M 2025-06
Pfizer USD 4.51B 734M 2026-03
PTC Therapeutics USD 25.48M 20M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Sarepta Therapeutics USD 70.38M 210.46M 2026-03
Teva Pharmaceutical Industries USD 2.6B 65M 2026-03
United Therapeutics USD 498.3M 491.2M 2026-03
Vertex Pharmaceuticals USD 3.47B 40.6M 2026-03